Therapeutic Areas: Oncology | Dermatology | Family Medicine

Metastatic Melanoma Clinical Trials


A listing of Metastatic Melanoma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Arizona

Scottsdale : Mayo Clinic Arizona - Cancer Clinical Research Unit

Patients are needed to participate in a clinical research study evaluating CDX-1127

Tucson : The University of Arizona Cancer Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Tucson : University Arizona Cancer Center

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Tucson : The University of Arizona Cancer Center

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

California

:Los Angeles : The Angeles Clinic and Research Institute

Patients are needed to participate in a clinical research study of TH-302 to evaluate Metastatic Melanoma

La Jolla : Moores UCSD Cancer Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

La Jolla : Moores UCSD Cancer Center

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

La Jolla : Moores UCSD Cancer Center

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Los Angeles : USC Norris Cancer Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Los Angeles :

A clinical research study of INCB024360 in combination with ipilimumab and Placebo in combination with ipilimumab for the treatment of Metastatic Melanoma

Stanford : Stanford Cancer Center - Stanford University

Patients are needed to participate in a clinical research study evaluating CDX-1127

Colorado

Aurora : University of Colorado Cancer Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Connecticut

New Haven : Smilow Cancer Hospital at Yale New Haven

A clinical trial to evaluate treatments using Vemurafenib for patients with Melanoma [C04.557.465.625.650.510]

District of Columbia

Washington : Georgetown University Medical Center

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

Washington : Washington Cancer Institute at MedStar Washington Hospital Center

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

Florida

Miami :

A clinical research study of INCB024360 in combination with ipilimumab and Placebo in combination with ipilimumab for the treatment of Metastatic Melanoma

Miami Beach : Mount Sinai Medical Center Comprehensive Cancer Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Miami Beach : MSMC Research Program

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Miami Beach : MSMC Research Program

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Tampa : H. Lee Moffitt Cancer Center and Research Institute

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Tampa :

A clinical research study of INCB024360 in combination with ipilimumab and Placebo in combination with ipilimumab for the treatment of Metastatic Melanoma

Tampa : H. Lee Moffitt Cancer Center and Research Institute

Patients are needed to participate in a clinical research study for the treatment of Metastatic Melanoma

Georgia

Atlanta : Emory University Winship Cancer Institute

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Atlanta : Emory University School of Medicine

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Augusta : Georgia Regents University

A Phase 1/Phase 2 clinical study for patients with Metastatic Melanoma, Stage III Melanoma or Stage IV Melanoma

Illinois

Chicago :

A clinical research study of INCB024360 in combination with ipilimumab and Placebo in combination with ipilimumab for the treatment of Metastatic Melanoma

Maywood : Loyola University Medical Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Maywood : Loyola University Medical Center, Div of Hematology/Oncology

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Park Ridge : Oncology Specialists, SC

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Park Ridge : Luther General Cancer Care Institute

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Park Ridge : Oncology Specialists, SC

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Indiana

Indianapolis : Indiana University Melvin and Bren Simon Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Indianapolis : Indiana University

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Iowa

Iowa City : University of Iowa Hospitals and Clinics

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Iowa City : University of Iowa Hospitals and Clinics

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Iowa City : University of Iowa Hospitals & Clinics

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Iowa City : University of Iowa Hospitals and Clinics

Patients are needed to participate in a clinical research study evaluating Temozolomide, Decitabine, Panobinostat for the treatment of Metastatic Melanoma

Iowa City : University of Iowa Hospitals & Clinics

Patients are needed to participate in a clinical research study evaluating Vemurafenib, Decitabine for the treatment of Metastatic Melanoma, Melanoma, BRAF-mutated Metastatic Melanoma or V600EBRAF-mutated Metastatic Melanoma

Kansas

Kansas City : University of Kansas Hospital

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Louisiana

Baton Rouge : The Baton Rouge Clinic, AMC

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Baton Rouge : Hematology/Oncology Clinic

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Maryland

Baltimore : Harry and Jeannette Weinberg Cancer Institute at Franklin Square

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

Lutherville : Johns Hopkins

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Lutherville : Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins

A clinical trial seeking patients for a research study for the treatment of Advanced Melanoma or Metastatic Melanoma

Lutherville : Johns Hopkins Medicine

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Massachusetts

Boston : Beth Israel Deaconess Medical Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Boston : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Boston : Beth Israel Deaconess Medical Center (BIDMC)

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

Boston : Dana-Farber Cancer Institute

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

Michigan

Ann Arbor : University of Michigan Health System

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Ann Arbor : University of Michigan, Comprehensive Cancer Center

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Detroit : Barbara Ann Karmanos Cancer Institute

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Detroit : Karmanos Cancer Institute

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Detroit : Karmanos Cancer Institute

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Minnesota

Minneapolis : University of Minnesota Masonic Cancer Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Minneapolis : University of Minnesota Masonic Cancer Center

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Rochester : Mayo Clinic

Patients are needed to participate in a clinical research study evaluating CDX-1127

Missouri

St. Louis : Saint Louis University Cancer Cener

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Nebraska

Omaha : Midwest Cancer Center - Legacy

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Omaha : Nebraska Cancer Specialists, Midwest Cancer Center - Legacy

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

New Hampshire

Lebanon : Dartmouth Hitchcock Medical Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Lebanon : Dartmouth-Hitchcock Medical Center

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

New Jersey

Hackensack : Hackensack University Medical Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Hackensack : John Theurer Cancer Center at Hackensack University Medical Center

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

New York

New York : Saint Luke's-Roosevelt Hospital Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

New York : Columbia University/Herbert Irving Comprehensive Cancer Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

New York : Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

New York : Memorial Sloan Kettering Cancer Ctr

A clinical trial seeking patients for a research study for the treatment of Advanced Melanoma or Metastatic Melanoma

New York : Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

New York : Icahn School of Medicine at Mount Sinai Hess Center for Science and Medicine

Patients are needed to participate in a clinical research study evaluating CDX-1127

New York : NYU Langone Medical Center

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

New York : NYU Clinical Cancer Center

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

North Carolina

Chapel Hill : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Charlotte : Blumenthal Cancer Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Durham : Duke University Medical Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Durham :

A clinical research study of INCB024360 in combination with ipilimumab and Placebo in combination with ipilimumab for the treatment of Metastatic Melanoma

Durham : Duke University Health System

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Winston-Salem : Wake Forest University Baptist Medical Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Winston-Salem : Wake Forest Baptist Health

A clinical trial seeking patients for a research study for the treatment of Stage IV Melanoma or Metastatic Melanoma

Ohio

Cincinnati : The Christ Hospital Cancer Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Cincinnati : The Christ Hospital Cancer Center

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Cincinnati : The Christ Hospital

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Cleveland : University Hospitals Siedman Cancer Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Cleveland : Case Comprehensive Cancer Center

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Columbus : The Ohio State University Comprehensive Cancer Center

Patients are needed to participate in a clinical research study evaluating CDX-1127

Oregon

Portland : Providence Portland Medical Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Portland : Providence Cancer Center

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Portland : Providence Portland Medical Center

A clinical trial seeking patients for a research study for the treatment of Advanced Melanoma or Metastatic Melanoma

Portland : Providence Cancer Center

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Portland : Providence Portland Medical Center

A Phase 1 clinical study for patients with Metastatic Melanoma

Portland : Oregon Health and Science University

Patients are needed to participate in a clinical research study evaluating CDX-1127

Pennsylvania

Bethlehem : Saint Luke's Hospital and Health Network

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Easton : St. Luke's Hospital, Anderson Campus

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Philadelphia :

A clinical research study of INCB024360 in combination with ipilimumab and Placebo in combination with ipilimumab for the treatment of Metastatic Melanoma

Philadelphia : Fox Chase Cancer Center

A Phase 1 clinical study for patients with Melanoma, Metastatic Melanoma or Solid Tumor

Pittsburgh : Hillman Cancer Research Pavilion, Div. of Medical Oncology

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Pittsburgh : UPMC Cancer Centers

A clinical research study of vemurafenib + HD IL-2 for the treatment of Metastatic Melanoma

Pittsburgh : GSK Investigational Site Updated

A clinical trial to evaluate treatments using Dabrafenib 150 mg and Trametinib 2.0 mg for patients with Melanoma and Brain Metastases

Pittsburgh : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Pittsburgh : University of Pittsburgh Medical Center

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

Tennessee

Knoxville : University of Tennessee Medical Center

A clinical trial seeking patients for a research study for the treatment of Stage IV Melanoma or Metastatic Melanoma

Nashville : Sarah Cannon Research Institute

Patients are needed to participate in a clinical research study evaluating CDX-1127

Nashville : Vanderbilt-Ingram Cancer Center

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

Texas

Dallas : Mary Crowley Cancer Research Centers - Medical City

Patients are needed to participate in a clinical research study evaluating CDX-1127

Houston : MD Anderson Cancer Center

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Houston : MD Anderson Cancer Center

A clinical trial seeking patients for a research study for the treatment of Metastatic Melanoma

Houston : University of Texas MD Anderson Cancer Center

A clinical trial to evaluate treatments using investigational drug INGN 241 for patients with Malignant Melanoma or Neoplasm Metastasis

Houston : University of Texas MD Anderson Cancer Center

A Phase 2 clinical study for patients with Melanoma

Houston : UT MD Andreson Cancer Center

Patients are needed to participate in a clinical research study of GSK2118436 and GSK1120212 to evaluate Melanoma

San Antonio : The START Center

A Phase 1 clinical study for patients with Melanoma, Metastatic Melanoma or Solid Tumor

Utah

Salt Lake City : Huntsman Cancer Institute

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Virginia

Charlottesville : University Of Virginia Health System

A clinical trial seeking patients for a research study for the treatment of Advanced Melanoma or Metastatic Melanoma

Washington

Seattle : Seattle Cancer Care Alliance

A clinical trial seeking patients for a research study for the treatment of Advanced Melanoma or Metastatic Melanoma

Seattle : University of Washington Medical Center

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

Seattle : Seattle Cancer Care Alliance

Patients are needed to participate in a clinical research study evaluating Vemurafenib and Bevacizumab for the treatment of Melanoma or Metastatic Melanoma

Wisconsin

Franklin : Wheaton Franciscan Cancer Care

A clinical study for patients with Metastatic Renal Cell Carcinoma or Metastatic Melanoma

Australia

Heidelberg : Austin Health, LICR Melbourne Austin Branch

A clinical research study of Bacillus Calmette-Guérin (BCG) vaccine and Ipilimumab for the treatment of Metastatic Melanoma

Melbourne : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

North Sydney : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Belgium

Brussels : Cliniques universitaires Saint-Luc, Centre du Cancer

A Phase 1/Phase 2 clinical study for patients with Melanoma

Canada

Edmonton : Cross Cancer Institute

Patients are needed to participate in a clinical research study of TH-302 to evaluate Metastatic Melanoma

Hamilton : Juravinski Cancer Centre

Patients are needed to participate in a clinical research study of TH-302 to evaluate Metastatic Melanoma

London : London Health Sciences Centre

Patients are needed to participate in a clinical research study of TH-302 to evaluate Metastatic Melanoma

Toronto : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Toronto : Princess Margaret Hospital

Patients are needed to participate in a clinical research study of TH-302 to evaluate Metastatic Melanoma

France

Boulogne-Billancourt : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Lille : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Marseille : Hôpital Sainte Marguerite

Patients are needed to participate in a clinical research study evaluating masitinib and Dacarbazine for the treatment of Metastatic Melanoma

Marseille Cedex 5 : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Paris Cedex 10 : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Rennes Cedex : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Villejuif cedex : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Italy

Milan : Fondazione IRCCS Istituto Nazionale dei Tumori

A clinical research study of L19IL2+L19TNF for the treatment of Malignant Melanoma, Skin

Padova : Vanna Chiarion-Sileni, MD

A clinical trial to evaluate treatments using Anti-B-RAF for patients with Metastatic Melanoma

Siena : Azienda Ospedaliera Universitaria Senese

A clinical research study of L19IL2+L19TNF for the treatment of Malignant Melanoma, Skin

Netherlands

Amsterdam : Local Institution

A clinical trial seeking patients for a research study for the treatment of Advanced Melanoma or Metastatic Melanoma

Spain

Barcelona : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Las Palmas De Gran Canaria : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Madrid : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Dabrafenib and Trametinib for the treatment of Melanoma and Brain Metastases

Pamplona : Local Institution

A clinical trial seeking patients for a research study for the treatment of Advanced Melanoma or Metastatic Melanoma

United Kingdom

Cambridge : Cambridge University Hospitals NHS Foundation Trust (Addenbrooke's Hospital)

A Phase 1 clinical study for patients with Melanoma, Metastatic Melanoma or Solid Tumor

London : The Royal Marsden Hospital

A Phase 1 clinical study for patients with Melanoma, Metastatic Melanoma or Solid Tumor

Manchester : The Christie NHS Foundation Trust

A Phase 1 clinical study for patients with Melanoma, Metastatic Melanoma or Solid Tumor

Newcastle upon Tyne : Newcastle upon Tyne Hospitals

A Phase 1 clinical study for patients with Melanoma, Metastatic Melanoma or Solid Tumor

Oxford : Oxford University Hospitals NHS Trust

A Phase 1 clinical study for patients with Melanoma, Metastatic Melanoma or Solid Tumor